收费全文 | 42228篇 |
免费 | 2741篇 |
国内免费 | 193篇 |
医药卫生 | 45162篇 |
2024年 | 26篇 |
2023年 | 276篇 |
2022年 | 273篇 |
2021年 | 1213篇 |
2020年 | 731篇 |
2019年 | 1166篇 |
2018年 | 1401篇 |
2017年 | 976篇 |
2016年 | 1022篇 |
2015年 | 1227篇 |
2014年 | 1750篇 |
2013年 | 2218篇 |
2012年 | 3282篇 |
2011年 | 3485篇 |
2010年 | 1998篇 |
2009年 | 1920篇 |
2008年 | 2898篇 |
2007年 | 3032篇 |
2006年 | 2765篇 |
2005年 | 2649篇 |
2004年 | 2367篇 |
2003年 | 2224篇 |
2002年 | 1962篇 |
2001年 | 358篇 |
2000年 | 233篇 |
1999年 | 318篇 |
1998年 | 421篇 |
1997年 | 348篇 |
1996年 | 246篇 |
1995年 | 234篇 |
1994年 | 194篇 |
1993年 | 188篇 |
1992年 | 121篇 |
1991年 | 136篇 |
1990年 | 99篇 |
1989年 | 91篇 |
1988年 | 79篇 |
1987年 | 81篇 |
1986年 | 81篇 |
1985年 | 88篇 |
1984年 | 99篇 |
1983年 | 96篇 |
1982年 | 93篇 |
1981年 | 90篇 |
1980年 | 70篇 |
1979年 | 60篇 |
1978年 | 43篇 |
1977年 | 28篇 |
1975年 | 36篇 |
1974年 | 29篇 |
Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.
Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease. 相似文献
Cerebellar mutism syndrome (CMS) occurs in one out of four children after posterior fossa tumor surgery, with open questions regarding risk factors, pathophysiology, and prevention strategies. Because of similarities between several cerebellar syndromes, a common pathophysiology with damage to the dentato-thalamo-cortical and dentato-rubro-olivary pathways has been proposed. Hypertrophic olivary degeneration (HOD) is an imaging correlate of cerebellar injury observed for instance in stroke patients. Aim of this study was to investigate whether the occurrence and severity of CMS correlates with the extent of damage to the relevant anatomical structures and whether HOD is a time-dependent postoperative neuroimaging correlate of CMS. We performed a retrospective single center study of CMS patients compared with matched non-CMS controls. CMS occurred in 10 children (13% of the overall cohort) with a median age of 8 years. Dentate nucleus (DN) injury significantly correlated with CMS, and superior cerebellar peduncle (SCP) injury was associated by tendency. HOD was observed as a dynamic neuroimaging phenomenon in the postoperative course and its presence significantly correlated with CMS and DN injury. Children who later developed HOD had an earlier onset and tended to have longer persistence of CMS. These findings can guide surgical measures to protect the DN and SCP during posterior fossa tumor resections and to avoid a high damage burden (i.e., bilateral damage). Development of intraoperative neuromonitoring of the cerebellar efferent pathways as well as improved preoperative risk stratification could help to establish a patient-specific strategy with optimal balance between degree of resection and functional integrity.
相似文献